Amsterdam's NLP demand centers on trade document processing, financial services, life sciences, and legal services. Trade document intelligence: the Netherlands handles 30% of all goods entering the EU. This trade generates millions of documents annually in multiple languages: commercial invoices (in the exporter's language — English from UK/US, German from DACH region, Chinese from Asian suppliers), bills of lading (standardised but with carrier-specific variations), certificates of origin (government-issued in the country of origin — formatting and language varies by country), customs declarations (Dutch — Douane ATLAS format), and trade compliance documents (sanction screening results, dual-use goods assessments, preferential origin calculations). NLP for trade documents must handle: multilingual extraction (pulling the same data fields from invoices in 12+ languages), entity resolution across languages (matching "Siemens AG" in a German invoice to "Siemens" in an English certificate of origin), and classification of goods descriptions for customs coding (mapping natural language product descriptions to HS/CN tariff codes). Financial text analytics: Dutch banks process enormous text volumes — customer correspondence in Dutch and English, transaction narratives for AML monitoring, regulatory publications from DNB/AFM, and cross-border financial documentation. AML text analytics is particularly important: the Netherlands faced significant AML enforcement (ING paid €775M in 2018, ABN AMRO paid €480M in 2021) — driving intensive investment in NLP-powered transaction monitoring and suspicious activity detection. Dutch AML text analysis processes: transaction narratives (short text descriptions accompanying payments — in Dutch, English, and other languages), SAR (Suspicious Activity Report) narratives for KoFIU submission, and customer due diligence documentation (KYC files containing correspondence, identity documents, and business descriptions in multiple languages). Life sciences NLP: Amsterdam's pharma corridor manages clinical trials across 15+ EU member states. Clinical trial documentation includes: protocols (English — standardised ICH GCP format), patient consent forms (translated into each participating country's language), adverse event reports (often in the local language of the reporting site — a serious adverse event at a Spanish trial site arrives in Spanish), clinical study reports (English, but referencing source data in multiple languages), and regulatory correspondence (EMA — English, national authorities — in local languages). NLP extracts structured data from these multilingual clinical documents for pharmacovigilance, trial monitoring, and regulatory submission.